SPOTLIGHT -
Daily audio coverage of the 2007 AAO annual meeting.
New approach to foveal holes: Light, sound and nutraceuticals
Novel treatment results in macular hole closure.
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
New strategies for severe ocular surface and corneal disease
Regenerative technologies are providing an influx of options.
Updates From Angiogenesis-2022
COPHy 2023: The pros and cons of managing AMD with home monitoring
The various aspects of home monitoring for patients with age-related macular degeneration are discussed in this point/counterpoint by Prof. Rufino Silva, University of Coimbra / Coimbra Hospital and University Centre, Portugal, and Univ.-Prof. Dr. med. Robert P. Finger, PhD, Department of Ophthalmology, University of Bonn, Germany, during the 14th annual Congress on Controversies in Ophthalmology in Lisbon, Portugal.
COPHy 2023: Thyroid eye disease: should all patients be offered teprotumumab?
Pedro Fonseca, MD, Coimbra Hospital and University Centre, Portugal, and Andrew G. Lee, MD, Blanton Eye Institute, Houston Methodist, Texas, United States, discuss the various pros and cons of offering teprotumumab for all patients with thyroid eye disease.
